Published on 19 Apr 2024 on Simply Wall St. via Yahoo Finance
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
Amicus Therapeutics, Inc. (NASDAQ:FOLD) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. On 31 December 2023, the US$3.1b market-cap company posted a loss of US$152m for its most recent financial year. The most pressing concern for investors is Amicus Therapeutics' path to profitability – when will it breakeven? In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.
Check out our latest analysis for Amicus Therapeutics